Articles from: VRX (Valeant Pharmaceuticals International) (MSN Money)
 |
|
|
|
|
| Next Page
| |
|
|
| Goldman: Hedge Funds Move Into Tech In Q1; 15 New Companies Emerge As Key H (more) | 2011 05 23 |
|
|
| Jeremy Grantham's Buy Ideas May Again Double the S&P 500's Return (more) | 2011 05 18 |
|
| Kinerase® Introduces 'Change Your Skin, Change Your Life' Charity Campaign (more) | 2011 05 17 |
|
|
|
|
| Valeant Pharmaceuticals to Webcast 2011 Annual Meeting of Shareholders (more) | 2011 05 11 |
|
|
|
|
|
|
|
|
| Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results (more) | 2011 05 09 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Valeant Pharmaceuticals International Stock Falls On Unusually High Volume (more) | 2011 05 02 |
|
| Cephalon Acquisition Expands Teva's Brand Drug Business; Valeant to Walk Aw (more) | 2011 05 02 |
|
|
| Valeant Pharmaceuticals Congratulates Teva and Cephalon on Their Transactio (more) | 2011 05 02 |
|
|
|
| Searching for Blockbuster Drugs: Teva Buying Cephalon for $6.8 Billion (more) | 2011 05 02 |
|
|
|
| Valeant Pharmaceuticals to Announce 2011 First Quarter Results on May 9, 20 (more) | 2011 04 29 |
|
|
| Equity Research on Valeant Pharmaceuticals International and Hospira Inc. - (more) | 2011 04 27 |
|
| The Zacks Analyst Blog Highlights: United Continental Holdings, Delta Air L (more) | 2011 04 26 |
|
|
|
|
|
|
| Valeant Pharmaceuticals Announces Letter to Cephalon Stockholders (more) | 2011 04 21 |
|
|
| Next Page
| |
